Results 161 to 170 of about 30,645 (194)
Some of the next articles are maybe not open access.
Journal of Gastroenterology and Hepatology, 2010
AbstractBackground and Aim: To evaluate the usefulness of quantitative hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) for predicting HBeAg seroconversion in chronic hepatitis B patients treated with conventional interferon (IFN) alfa‐2b or PegIFN alfa‐2b.Methods: Fifty‐eight patients were enrolled; 29 for the training group and
Hui, Ma, Rui-Feng, Yang, Lai, Wei
openaire +2 more sources
AbstractBackground and Aim: To evaluate the usefulness of quantitative hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) for predicting HBeAg seroconversion in chronic hepatitis B patients treated with conventional interferon (IFN) alfa‐2b or PegIFN alfa‐2b.Methods: Fifty‐eight patients were enrolled; 29 for the training group and
Hui, Ma, Rui-Feng, Yang, Lai, Wei
openaire +2 more sources
HBeAg Seroconversion in Children Infected During Early Childhood With Hepatitis B Virus [PDF]
Seroconversion of hepatitis B e-antigen (HBeAg) to anti-HBe is associated with lower viral load and liver diseases.The purpose of this study was to assess the seroconversion rate of HBeAg to anti-HBe in children who acquired hepatitis B virus (HBV) infection during early childhood.From September 1990 to December 2010, 139 HBeAg-positive children were ...
Ali Bijani
exaly +3 more sources
Effect of virologic response on posttreatment durability of lamivudine-induced HBeAg seroconversion
Journal of Hepatology, 2001Lamivudine‐induced HBeAg seroconversion may not be durable in Korean patients with hepatitis B virus (HBV) infection. It is unknown whether virological response during lamivudine treatment affects the post‐treatment outcome. We retrospectively analysed 124 consecutive HBeAg‐positive chronic hepatitis B (CHB) patients treated with lamivudine. Lamivudine
K M, Lee +5 more
openaire +3 more sources
Gastroenterology, 2009
This study aimed to identify the predictors for early hepatitis B e antigen (HBeAg) seroconversion following acute exacerbation (AE) in patients with HBeAg-positive chronic hepatitis B (CHB).A total of 151 patients with HBeAg-positive CHB and AE were consecutively enrolled. AE was defined as an elevation of alanine aminotransferase level to more than 5
Hyoung Su, Kim +6 more
openaire +2 more sources
This study aimed to identify the predictors for early hepatitis B e antigen (HBeAg) seroconversion following acute exacerbation (AE) in patients with HBeAg-positive chronic hepatitis B (CHB).A total of 151 patients with HBeAg-positive CHB and AE were consecutively enrolled. AE was defined as an elevation of alanine aminotransferase level to more than 5
Hyoung Su, Kim +6 more
openaire +2 more sources
Different Models of HBeAg Seroconversion Predicated by On-Treatment ALT and HBV DNA Profiles
Journal of Viral Hepatitis, 2009Summary. Pretreatment alanine transaminase (ALT) elevation may be used as a predictor for higher hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B patients. However, the role of dynamic changes of on‐treatment ALT for seroconversion is unknown.
Hong You, Xiaojuan Ou, Baoen Wang
exaly +3 more sources
Hepatology International, 2012
We investigated whether the combined presence and evolution of hepatitis B virus (HBV) mutant strains in the hepatitis B e antigen (HBeAg)-positive status can predict clinical outcomes after HBeAg seroconversion.One hundred and eighty-six patients with spontaneous HBeAg seroconversion were enrolled into this longitudinal study.
Chien-Hung, Chen +6 more
openaire +2 more sources
We investigated whether the combined presence and evolution of hepatitis B virus (HBV) mutant strains in the hepatitis B e antigen (HBeAg)-positive status can predict clinical outcomes after HBeAg seroconversion.One hundred and eighty-six patients with spontaneous HBeAg seroconversion were enrolled into this longitudinal study.
Chien-Hung, Chen +6 more
openaire +2 more sources
Journal of Medical Virology, 2014
Spontaneous hepatitis B virus (HBV) e antigen (HBeAg) seroconversion is associated with reduced risk of liver‐related complications, but is poorly understood. In this study, 113 chronic hepatitis B patients in the immune active HBeAg‐positive phase were followed up for 76 weeks.
Guangjun, Song +3 more
openaire +2 more sources
Spontaneous hepatitis B virus (HBV) e antigen (HBeAg) seroconversion is associated with reduced risk of liver‐related complications, but is poorly understood. In this study, 113 chronic hepatitis B patients in the immune active HBeAg‐positive phase were followed up for 76 weeks.
Guangjun, Song +3 more
openaire +2 more sources
ASSESSMENT OF PATIENTS WITH THERAPY INDUCED HBEAG SEROCONVERSION: A REAL-LIFE EXPERIENCE
Acta Medica Mediterranea, 2022<p style="text-align:justify;font-size:9px;font-family:Times;"><b><i>Objective:</i></b><i> We aimed to evaluate clinical and laboratory features of chronic hepatitis B virus (HBV) patients before and after the therapy-induced Hepatitis B envelope antigen (HBeAg) seroconversion.<span> </span></
openaire +1 more source
2010
AIM: To determine the virological and biochemical relapse rates in Chinese CHB patients with lamivudine-induced HBeAg seroconversion after stopping lamivudine therapy, and to identify significant viral or biochemical factors predictive of subsequent relapse.
Wong, DKH +6 more
openaire +2 more sources
AIM: To determine the virological and biochemical relapse rates in Chinese CHB patients with lamivudine-induced HBeAg seroconversion after stopping lamivudine therapy, and to identify significant viral or biochemical factors predictive of subsequent relapse.
Wong, DKH +6 more
openaire +2 more sources
Increase risk of HBeAg-negative chronic hepatitis B with older age at HBeAg seroconversion
2010Background: Recent evidence suggests that delayed HBeAg seroconversion is associated with poorer outcome. We aim to determine the incidence of HBeAg-negative chronic hepatitis B (CHB) according to the age at which HBeAg seroconversion occurs. Methods: Chronic hepatitis B patients with natural HBeAg seroconversion and over 12 months follow-up after ...
Fung, JYY +4 more
openaire +2 more sources

